Tbilisi State Medical University Faculty
|
Pharmacy |
Program Title
|
Pharmaceutical Analysis |
Awarded
academic qualification/degree |
|
Program Director
|
Associate Professor Tamar Chilkviladze |
Credit Value of the Program |
120
ECTS credits |
Language of Instruction |
Georgian |
Program Objectives |
Healthcare
and improvement are one of the priorities of the state and while society.
Efficient healthcare system definitely implies providing the population with
quality efficient and safe pharmaceutical product, protection form hazardous,
falsified, non- useful and expired means of treatment; taking substantial
measures against drug addiction and toxicomania. Pharmaceutical analysis is the most significant element in ensuring the
quality of medicine and good of medical purpose; in the area of
standardization of means of treatment, pharmacopeia, pharmacognostic,
pharmaco- kinetic and chemical-toxicological analysis. The aim of the MA program is to train the pharmacy worker of respective qualification who will be able to work independently at the laboratories of quality control of medicine and medicine control, narrow profile scientific- research establishments, meet the requirements of GMP and ISO, be guided by the best laboratory practices principle and serve as the guarantee of quality and security of the production existing at the country’s pharmaceutical market. |
Prerequisite(s) /Requirements for admission to the program |
Admission
to the program is regulated by the rule established by the legislation of
Georgia and by the regulation approved by the Academic Council of Tbilisi
State Medical University on the master's degree (Decisions of the Academic
Council of TSSU: №24/5, 7.05.2012, №24/3, 15.05.2017): - A person with a bachelor's degree or
an equivalent degree has the right to study at the master's level; - In order to
obtain the right to continue studying at the master's program, it is
necessary to pass the common master's exam (A test) and the exams established by Tbilisi State
Medical University in the
specialty and English language (overcoming the 50%+1 threshold). Internal university exams are held in the
exam center of TSMU, in test form; The exam in the specialty includes 3
profile training courses: pharmacognosy, pharmaceutical chemistry and
toxicological chemistry, which
are studied within
the framework of undergraduate programs. - Only those
candidates for master's degree who have passed the minimum competence limit
established by Georgian legislation in the common master's exam have the
right to participate in the exam/exams established by the higher educational
institution; - Enrollment in the master's program is carried out within the framework of the pre-announced admission quota, according to the competition rules; - Access by mobility is done in accordance with Georgian legislation and TSMU regulations. |
Program short
description |
- Master's
program is focused on pharmacopoeia, on the in-depth study of
pharmacogenetic, pharmacokinetic and toxicological analysis, on the study of
external and internal challenges acting in this direction, obtained on
critical analysis of results, on generating new ideas for solving complex
problems and searching for solutions; - To obtain the
academic degree of Master of Pharmaceutical Analysis, the student needs to accumulate
120 ECTS credits, including; - Profile main
training courses - 44 credits; Non-professional basic training courses - 6
credits, Optional school courses - 10 credits; Professional practice - 30 credits;
Research component - 30 credits The third semester is entirely devoted to
four professional practices, which
students undergo on the basis of the memorandums and within the framework of the
agreements. In
the fourth semester, the research component is completed, which provides for
the independent research conducted by the master's student in the relevant
direction, the results of which are reflected in the master's thesis. A Master in Pharmaceutical Analysis can be employed with a relevant competency, or continue their studies in a Ph.D.
|
Student
knowledge assessment system |
Assessment of student’s/MA candidate’s work envisages: a.
Mid-term evaluation (all compulsory components to be fulfilled by
the student, which are envisaged in accordance
with the syllabi of the
training course/module); b.
Assessment of the final
exam. Maximum assessment score of the course/module is 100 out of which
40 points are allocated
to the maximum of
the final exam. Main methods
of assessment used are: testing, oral or combined summative exam. There are
five types of positive and two types
of negative assessment. Positive
assessments are: a. (A) (Excellent) - 91-100 % of maximum assessment; b. (B) Very good – 81-90 % of
maximum assessment; c.
(C) Good – 71-80 % of maximum assessment; d.
(D) Satisfactory – 61-70
% of maximum assessment; e.
(E) Sufficient - 51-60 % of maximum assessment Negative
assessments are: a.
(FX) Failed to pass – 41-50 % of maximum assessment,
which implies that the students’ needs
to work more
to pass and gets the right to take an additional exam after
independent work b.
(F) failed – 40
% of maximum assessment and less which
means that the work
carried out by the student is not enough and she/he
has to study the subject again The correlation between various
components of assessment is defined by the syllabus of the separate course of the MA program. The share of the exam in the final
assessment (mid-term and the
final exams) does not exceed 40 %. The
MA student has the right to pass the additional exam in the same semester.
The period between final and respective
additional exams should not be less than 5 days. Based on the criteria envisaged by the educational program, practical work, MA and/or other
types of work are assessed by the 100- point system. Members of the committee of defending
MA theses assess the MA work
by the score of 0-100. The score is calculated by the members
ofthe qualifying board of defending MA theseson the basis of the grade
point average of the
sum of the scores granted. In case of assessing the MA thesis at the score of 51 and more, the work is
considered defended based on the
following distribution of assessment scores: 91-100 – Best piece
of work; 81-90 – Very good
piece of work; 71-80
– Good piece
of work; 61-70 – Average piece
of work; 51-60 – Satisfactory piece
of work; 0-50
– non-satisfactory piece
of work; In case
of the failure to appear at the defense of the MA thesis
due to a reasonable cause (illness, etc.) the work can be submitted within the
period of 1 month or at the following defense with the consent of the board of the
respective department. In
case of receiving less than 51 scores at the public defense, it is possible
to re-submit the thesis and defend
it at the coming defense on the
basis of the board of the respective faculty. The MA thesis may be
submitted for defense not less than two times, by retaining the teaching component. |
Learning Outcomes |
Knowledge and understanding - after
completing the program, the master of pharmaceutical analysis will have
a deep, systematic knowledge of the
field, will be able to critically understand his own activities, which
includes the latest achievements in the field and creates a basis for
innovation, development of new, original ideas. After
completing the master's program, the master of pharmaceutical analysis will
know: -
Methods of standardization and analysis of medicinal substances, drug forms; -
Standardization and analysis methods of medicinal
plants, herbal preparations; -
Theoretical foundations of separation of
biologically active substances from plants/plant raw materials; -
Modern methods of chemical and
toxicological research; Specificity of the analysis of narcotic and toxic substances; -
Fundamentals of the pharmacokinetics of medicinal
products, pharmaceutical and biological equivalence of drugs, rational pharmacotherapy; -
Theoretical and legal
bases of registration of pharmaceutical product. Ability - After completing the Master's program, the Master of Pharmaceutical
Analysis can independently: -
Standardization and
quality assessment of medicinal substances, drug forms; -
Standardization and quality assessment of medicinal plants,
phyto preparations; -
Biologically active from
plant raw material separation of substances; -
Assessment of pharmaceutical and biological
equivalence of drugs; determining pharmacokinetic parameters; Predicting
rational pharmacotherapy; -
Narcotics and toxic
substances court – chemical expertise; -
Preparation of pharmaceutical product
documentation and registration. Responsibility and autonomy After
completing the master's program, the Master of Pharmaceutical Analysis contributes to the development of knowledge and practice in the
field of pharmaceutical analysis by understanding and fulfilling his/her
place, role and responsibility in professional activity. can be based on an
objective assessment of their own skills, continuous Determining the need for learning for
professional development and planning independently. |
Fields of Graduate Employment |
The master of pharmaceutical analysis can independently use the acquired knowledge and practical skills in a scientific-research institute of the relevant profile, a drug agency, a pharmaceutical enterprise, drug quality control, drug quality assurance, food product quality control, pharmacokinetic and chemical-toxicological analysis laboratories, forensic examination bureau, in pharmaceutical companies, pharmacies; Also, within the scope of their competence - in clinics, chemical reagents facilities. |
Curriculum
MA Program in "Pharmaceutical Analysis".
N |
Study courses |
credits |
Hours |
Credit-volume |
||||||||
Among them |
I semester |
II semester |
III semester |
IV semester |
||||||||
contact |
lecturer |
seminar |
practice |
seminar |
Independent work |
|||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
1 |
Professional English
language |
4 |
48 |
|
|
|
48 |
76 |
4 |
|
|
1 |
2. |
Information technologies in science |
2 |
24 |
|
|
|
|
36 |
2 |
|
|
2. |
3. |
Pharmacopoeia analysis |
10 |
120 |
10 |
110 |
|
|
180 |
10 |
|
|
3. |
4. |
Pharmacokinetics |
6 |
72 |
12 |
60 |
|
|
108 |
6 |
|
|
4. |
5. |
Toxicological analysis |
6 |
72 |
12 |
60 |
|
|
108 |
6 |
|
|
5. |
6. |
Pharmacognostic analysis |
10 |
120 |
|
120 |
|
|
180 |
|
10 |
|
6. |
7 |
Standardization
of medicinal products |
10 |
120 |
60 |
60 |
|
|
180 |
|
10 |
|
7 |
8 |
Pharmaceutical product quality control organization |
3 |
36 |
20 |
16 |
|
|
54 |
|
3 |
|
8 |
9 |
Professional practice I (drug testing laboratory) |
8 |
96 |
|
96 |
|
|
144 |
|
|
8 |
9 |
10 |
"Global Test" |
8 |
96 |
|
96 |
|
|
144 |
|
|
8 |
10 |
11
|
Professional practice II |
6 |
72 |
|
72 |
|
|
108 |
|
|
6 |
11 . |
12 |
(Drug quality
laboratory of
"GMP" pharmaceutical enterprise) |
8 |
96 |
|
96 |
|
|
144 |
|
|
8 |
12 |
13 |
master's thesis |
30 |
360 |
|
|
|
|
540 |
|
|
|
30 |
|
||||||||||||
|
Elective study
courses |
|
|
|
|
|
|
|
|
|
|
|
14 |
Chromatographic methods in pharmaceutical
analysis |
2 |
24 |
|
24 |
|
|
36 |
2 |
|
|
|
15 |
Technical provision of pharmaceutical analysis from
plant raw materials |
2 |
24 |
|
24 |
|
|
36 |
2 |
|
|
|
16 |
Principles of screening of biologically active
natural compounds |
3 |
36 |
|
|
|
36 |
54 |
|
3 |
|
|
17 |
Forensic - biological examination of toxic plants |
3 |
36 |
|
36 |
|
|
54 |
|
3 |
|
|
18 |
Registration of biologically active additives and homeopathic remedies |
2 |
24 |
8 |
16 |
|
|
36 |
|
2 |
|
|
19 |
Registration of dental materials and
diagnostic equipment |
2 |
24 |
8 |
16 |
|
|
36 |
|
2 |
|
|
20 |
Registration
of veterinary, disinfection, disinfection, deratization
products |
2 |
24 |
6 |
18 |
|
|
36 |
|
2 |
|
|
21 |
Polypragmasy |
2 |
24 |
10 |
14 |
|
|
36 |
|
2 |
|
|
Copyright © 2018 | Created By Integral Web Studio